BLTE Q3 2025 Earnings — Belite Bio, Inc Revenue & Financial Results | Market Cap Arena

BLTEBelite Bio, Inc

$7B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$23M

Net Income

-$22M

EPS (Diluted)

$-0.65

QoQ Revenue Growth

NaN%

Balance Sheet

Total Assets

$282M

Total Liabilities

$8M

Stockholders' Equity

$274M

Cash & Equivalents

$157M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$23M	-$10M	-136.3%
Net Income	-$22M	-$9M	-149.9%